unknown
Stage
About
Niagen Bioscience (formerly ChromaDex) develops and commercializes the patented nicotinamide riboside (NR) ingredient Niagen® and conducts clinical research on NAD+ for applications in healthy aging, supplying ingredients and research support to supplement manufacturers and research institutions.
Explore Niagen Bioscience (formerly ChromaDex)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.